PMC:7264932 / 3533-3724 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"130","span":{"begin":4,"end":12},"obj":"Species"},{"id":"131","span":{"begin":41,"end":55},"obj":"Chemical"},{"id":"132","span":{"begin":132,"end":144},"obj":"Chemical"},{"id":"133","span":{"begin":149,"end":162},"obj":"Chemical"},{"id":"134","span":{"begin":77,"end":95},"obj":"Disease"},{"id":"135","span":{"begin":106,"end":121},"obj":"Disease"}],"attributes":[{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"Tax:9606"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"MESH:D000666"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:D065819"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:C508735"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"MESH:D009102"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:D017093"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T31","span":{"begin":106,"end":121},"obj":"Phenotype"}],"attributes":[{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0001399"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T40","span":{"begin":77,"end":95},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0043726"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T21","span":{"begin":54,"end":55},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T41","span":{"begin":132,"end":144},"obj":"Chemical"},{"id":"T42","span":{"begin":149,"end":162},"obj":"Chemical"}],"attributes":[{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_10023"},{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_85979"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}

{"project":"LitCovid-sentences","denotations":[{"id":"T34","span":{"begin":0,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives."}